Women in their thirties are most likely to be mistrustful of the COVID-19 vaccine, according to government research. A survey of 1000 Australians found 42 per cent of women aged 30 to 39 had concerns about the safety of the COVID-19 vaccine, the Sydney Morning Herald reported. Overall, 27 per cent of the population had… Read More »
Vaccine passports, hastily ushered in as a byproduct of the COVID-19 pandemic, are expected to become “widely available” during the first half of 2021. “Rest assured, the nerds are on it,” Brian Behlendorf, executive director of Linux Foundation, told CNN Business.1 The Linux Foundation has partnered with IBM, the COVID-19 Credentials Initiative and CommonPass, a… Read More »
Pfizer’s chairman and CEO proclaimed in a Pfizer company news release: “Today is a great day for science and humanity.” In that PR news release – but only in that format – Pfizer announced early results of “a vaccine efficacy rate above 90%, at 7 days after the second dose.” That’s about all we know… Read More »
UPDATE: The trial of the AZD1222 vaccine in the U.K. has already resumed after an independent investigation by the Medicines Health Regulatory Authority concluded it was safe to proceed. “AstraZeneca is committed to the safety of trial participants and the highest standards of conduct in clinical trials,” the company said in a September 12 press release.… Read More »